Use of anti-X a activity as a marker for heparin-induced bleeding in patients with APTT > 180 s.
Haliassos
A
A
Clin. Labs, Onassis Cardiac Surgery Center, Kallithea, Greece. mdb1@hol.gr
Melita-Manolis
H
H
Aggelaki
D
D
Tassi
D
D
Terzoglou
G
G
D000328:Adult; D000368:Aged; D016903:Drug Monitoring / Q000379:methods; D065427:Factor Xa Inhibitors; D006470:Hemorrhage / Q000139:chemically induced* / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control
D065427:Factor Xa Inhibitors; D006493:Heparin